3,5,4'-Tribromosalicylanilide
CAS: 87-10-5
Rif. 3D-FT111848
1g | Fuori produzione | ||
2g | Fuori produzione | ||
5g | Fuori produzione | ||
10g | Fuori produzione | ||
25g | Fuori produzione |
Informazioni sul prodotto
- 2-Hydroxybenzoic Acid 4-(1,1-Dimethylethyl)phenyl Ester
- 3,4′,5-Tribromosalicylanilide
- 3,5-Dibromo-6-hydroxybenz-p-bromanilide
- 3,5-Dibromo-N-(4-bromophenyl)-2-hydroxybenzamide
- 3,5-Dibromosalicylic acid p-bromoanilide
- 4-(2-Methyl-2-propanyl)phenyl salicylate
- 4-Tert-Butylphenyl 2-Hydroxybenzoate
- 4-tert-Butylphenyl Salicylate
- Agramed
- Benzamide, 3,5-dibromo-N-(4-bromophenyl)-2-hydroxy-
- Vedi altri sinonimi
- Benzoic Acid, 2-Hydroxy-, 4-(1,1-Dimethylethyl)Phenyl Ester
- NSC 20526
- Salicylanilide, 3,4′,5-tribromo-
- Salicylic Acid p-tert-Butylphenyl Ester
- Sherstat TBS
- TBS
- Temasept II
- Temasept IV
- Tempasept II
- Tribromsalan
- Trisanil
- Trisanyl
- Tuasal 100
- Tuasol
- Vancide TBS
- Wr 34912
3,5,4'-Tribromosalicylanilide is a fatty acid that is used as an antimicrobial agent. It has shown to be active against Gram-positive bacteria and some Gram-negative bacteria. 3,5,4'-Tribromosalicylanilide is a strong inhibitor of the production of fatty acids in human skin cells. It has been shown to have carcinogenic potential in animal studies. This compound also inhibits the growth of microorganisms that are resistant to benzalkonium chloride or hydroxylated glycol ethers. The analytical method for this compound is based on its ability to react with human serum proteins and benzalkonium chloride in a competitive manner.